Glenn Buene
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Bone health and treatments
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Ubiquitin and proteasome pathways 4
- TGF-β signaling in diseases 3
- Glycosylation and Glycoproteins Research 2
- Protein Degradation and Inhibitors 2
- Hematology 10
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Kristine Misund (8 shared papers)Anders Waage (10 shared papers)Anders Sundan (11 shared papers)Toril Holien (8 shared papers)Therese Standal (8 shared papers)Siv Helen Moen (7 shared papers)Marita Westhrin (7 shared papers)Katarzyna Anna Baranowska (4 shared papers)
- Journals
- Biomarker Research (2 papers)Oncotarget (2 papers)Blood (2 papers)iScience (1 paper)Blood Cancer Journal (1 paper)
- Partner nations
- NorwayNetherlandsSweden
In The Last Decade
Glenn Buene
14 papers receiving 303 citations
Peers
Comparison fields: 5 of 55
- Hematology 109
- Oncology 79
- Immunology 58
- Molecular Biology 168
- Cancer Research 33
Countries citing papers authored by Glenn Buene
This map shows the geographic impact of Glenn Buene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Buene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Buene more than expected).
Fields of papers citing papers by Glenn Buene
This network shows the impact of papers produced by Glenn Buene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Buene. The network helps show where Glenn Buene may publish in the future.
Co-authors
The 25 scholars most cited alongside Glenn Buene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 55 | |
| 2 | 2016 | 49 | |
| 3 | 2018 | 42 | |
| 4 | 2016 | 33 | |
| 5 | 2015 | 26 | |
| 6 | 2020 | 23 | |
| 7 | 2015 | 21 | |
| 8 | 2018 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2014 | 11 | |
| 11 | 2019 | 9 | |
| 12 | 2021 | 5 | |
| 13 | 2015 | 1 | |
| 14 | 2018 | 1 |
About Glenn Buene
Glenn Buene is a scholar working on Molecular Biology, Hematology, Oncology, Epidemiology and Immunology, having authored 14 papers that have together received 304 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Ubiquitin and proteasome pathways (4 papers), TGF-β signaling in diseases (3 papers), Glycosylation and Glycoproteins Research (2 papers), Protein Degradation and Inhibitors (2 papers), Chemokine receptors and signaling (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Liver physiology and pathology (1 paper). The work is most often cited by research in Hematology (109 citations), Oncology (79 citations), Immunology (58 citations), Molecular Biology (168 citations) and Cancer Research (33 citations). Glenn Buene has collaborated with scholars based in Norway, Netherlands and Sweden. Frequent co-authors include Kristine Misund, Anders Waage, Anders Sundan, Toril Holien, Therese Standal, Siv Helen Moen, Marita Westhrin, Katarzyna Anna Baranowska, Hanne Hella and Anne‐Marit Sponaas. Their work appears in journals such as Biomarker Research, Oncotarget, Blood, iScience and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.